Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corneal stromal collagen fibers are highly organized structural proteins predominantly composed of type I collagen, with additional contributions from types V, VI, XII, XIII, XIV, and XXIV collagen[1][5]. These fibers are assembled into narrow, uniform-diameter fibrils (∼30–31 nm), which are precisely arranged in parallel, superimposed lamellae throughout the corneal stroma[2][5]. The ordered architecture, aided by proteoglycans that maintain inter-fibrillar spacing, is essential for corneal transparency and refractive function[1][4]. Collagen fibers provide the main mechanical strength of the cornea and their organization is critical for both shape and optical properties. Disruption or alteration of the normal collagen fiber structure leads to loss of transparency and corneal diseases such as keratoconus, dystrophies, or opacity[6]. While not considered a drug target in the traditional sense (i.e., not a receptor, enzyme, or transporter), corneal stromal collagen fibers are a focus for research on tissue engineering, regenerative medicine, and interventions such as corneal cross-linking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal stromal collagen fiber.